News
-
Volcon ePowersports Obtains Floor Plan Program with Dealer Direct Financing
-
Aspire Biopharma Holdings, Inc., Provides Development Update on BUZZ BOMB(TM), its New Sublingual Pre-Workout Supplement, Expected to Launch in Third Quarter of 2025
-
MIRA Pharmaceuticals to Participate in BIO 2025 in Boston and Highlights Ongoing Progress Across Clinical Program
-
QNX Launches QNX Hypervisor 8.0 to Accelerate Embedded Software Development
-
Wellgistics Health Strengthens Executive Team and Board with Strategic Appointments to Accelerate Scale and Drive Shareholder Value
-
DEAG: Growth in revenue and earnings in line with plan in Q1 2025 – strong start to financial year 2025
-
Fuller, Smith & Turner PLC: Transaction in own shares
-
Funding Circle Holdings plc: POS-Transaction in Own Shares
-
Vonovia SE: AGM approves €1.22 dividend and appoints Michael Rüdiger and Dr Marcus Schenck to the Supervisory Board
-
CPI Europe starts the 2025 financial year with solid performance
-
Descriptif du programme de rachat d'actions - Mai 2025
-
Description of share-buyback program - May 2025
-
AXA a placé 1 milliard d’euros d’Obligations Restricted Tier 1 et 1 milliard d’euros d’Obligations Tier 2
-
AXA announces the placement of Euro 1 billion Restricted Tier 1 Notes and Euro 1 billion Tier 2 Notes
-
Chiffre d’affaires 2024/2025